Why the study?
Does apamin reduce alpha-adrenoceptor-mediated changes in plasma potassium in anaesthetized guinea-pigs?
Does apamin reduce alpha-adrenoceptor-mediated changes in plasma potassium in anaesthetized guinea-pigs?
Apamin selectively reduces the hyperkalaemic phase of alpha-adrenoceptor-mediated plasma potassium changes in guinea-pigs.
May guide mechanistic studies of alpha-adrenoceptor potassium responses; leaves open translation to humans.
An intravenous K+-sensitive electrode has been used to monitor plasma [K+] changes induced by adrenaline (1.4-6.8 micrograms kg-1) and amidephrine (14-340 micrograms kg-1) in anaesthetized guinea-pigs. A biphasic response consisting of an initial increase in [K+] followed, within 1 min, by a fall below baseline was observed with both agonists. Apamin (0.4-40 micrograms kg-1) reduced the hyperkalaemic phase of the response to amidephrine in a dose-related, non-competitive manner. The response to adrenaline was also reduced but to a lesser extent. Apamin caused little or no reduction of the hypokalaemic phase of the response to either agonist.
No takes yet. Share an insight, caveat, or question.
Rachel A. Coats (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: